Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun;43(6):703-716.
doi: 10.1002/pd.6345. Epub 2023 Apr 3.

Investigation into the genetics of fetal congenital lymphatic anomalies

Affiliations

Investigation into the genetics of fetal congenital lymphatic anomalies

Daniella Rogerson et al. Prenat Diagn. 2023 Jun.

Abstract

Objective: Congenital lymphatic anomalies (LAs) arise due to defects in lymphatic development and often present in utero as pleural effusion, chylothorax, nuchal and soft tissue edema, ascites, or hydrops. Many LAs are caused by single nucleotide variants, which are not detected on routine prenatal testing.

Methods: Demographic data were compared between two subcohorts, those with clinically significant fetal edema (CSFE) and isolated fetal edema. A targeted variant analysis of LA genes was performed using American College of Medical Genetics criteria on whole exome sequencing (WES) data generated for 71 fetal edema cases who remained undiagnosed after standard workup.

Results: CSFE cases had poor outcomes, including preterm delivery, demise, and maternal preeclampsia. Pathogenic and likely pathogenic variants were identified in 7% (5/71) of cases, including variants in RASopathy genes, RASA1, SOS1, PTPN11, and a novel PIEZO1 variant. Variants of uncertain significance (VOUS) were identified in 45% (32/71) of cases. In CSFEs, VOUS were found in CELSR1, EPHB4, TIE1, PIEZO1, ITGA9, RASopathy genes, SOS1, SOS2, and RAF1.

Conclusions: WES identified pathogenic and likely pathogenic variants and VOUS in LA genes in 51% of fetal edema cases, supporting WES and expanded hydrops panels in cases of idiopathic fetal hydrops and fluid collections.

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTEREST STATEMENT

None of the authors have conflicts of interest to disclose.

Figures

FIGURE 1
FIGURE 1
Flow chart of inclusion and exclusion criteria as applied to fetal edema cases.
FIGURE 2
FIGURE 2
Spectrum of fetal LAs on prenatal ultrasound. (A) Cystic hygroma, 12w (white arrows). (B) Scalp soft tissue edema, 21w (white arrows). (C) Hydrops with bilateral pleural effusion (white arrows) and trunk soft tissue edema (yellow arrows), 19w. (D) 3D ultrasound of an axillary cystic lymphatic malformation, 20w (white arrows). (E) Ascites, 26w (white arrows). (F) Pedal lymphedema, 22w (white arrows). w, weeks’ gestation.

References

    1. Brouillard P, Boon L, Vikkula M. Genetics of lymphatic anomalies. J Clin Invest. 2014;124(3):898–904. 10.1172/JCI71614 - DOI - PMC - PubMed
    1. Anomalies ISftSoV. ISSVA Classification for Vascular Anomalies; 2014.
    1. Bekker MN, van den Akker NM, de Mooij YM, Bartelings MM, van Vugt JM, Gittenberger-de Groot AC. Jugular lymphatic maldevelopment in Turner syndrome and trisomy 21: different anomalies leading to nuchal edema. Reprod Sci. 2008;15(3):295–304. 10.1177/1933719107314062 - DOI - PubMed
    1. Bellini C, Rutigliani M, Boccardo FM, et al. Nuchal translucency and lymphatic system maldevelopment. J Perinat Med. 2009;37(6):673–676. 10.1515/JPM.2009.107 - DOI - PubMed
    1. de Mooij YM, van den Akker NM, Bekker MN, Bartelings MM, van Vugt JM, Gittenberger-de Groot AC. Aberrant lymphatic development in euploid fetuses with increased nuchal translucency including Noonan syndrome. Prenat Diagn. 2011;31(2):159–166. 10.1002/pd.2666 - DOI - PubMed